Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2

Jason A. Somarelli, Samantha Shetler, Mohit K. Jolly, Xueyang Wang, Suzanne Bartholf Dewitt, Alexander J. Hish, Shivee Gilja, William C. Eward, Kathryn E. Ware, Herbert Levine, Andrew J. Armstrong, Mariano Garcia-Blanco

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Phenotypic plasticity involves a process in which cells transiently acquire phenotypic traits of another lineage. Two commonly studied types of phenotypic plasticity are epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET). In carcinomas, EMT drives invasion and metastatic dissemination, while MET is proposed to play a role in metastatic colonization. Phenotypic plasticity in sarcomas is not well studied; however, there is evidence that a subset of sarcomas undergo an MET-like phenomenon. While the exact mechanisms by which these transitions occur remain largely unknown, it is likely that some of the same master regulators that drive EMT and MET in carcinomas also act in sarcomas. In this study, we combined mathematical models with bench experiments to identify a core regulatory circuit that controls MET in sarcomas. This circuit comprises the microRNA 200 (miR-200) family, ZEB1, and GRHL2. Interestingly, combined expression of miR-200s and GRHL2 further upregulates epithelial genes to induce MET. This effect is phenocopied by downregulation of either ZEB1 or the ZEB1 cofactor, BRG1. In addition, an MET gene expression signature is prognostic for improved overall survival in sarcoma patients. Together, our results suggest that a miR-200, ZEB1, GRHL2 gene regulatory network may drive sarcoma cells to a more epithelial- like state and that this likely has prognostic relevance.

Original languageEnglish (US)
Pages (from-to)2503-2513
Number of pages11
JournalMolecular and Cellular Biology
Volume36
Issue number19
DOIs
StatePublished - 2016

Fingerprint

Epithelial-Mesenchymal Transition
MicroRNAs
Sarcoma
Carcinoma
Gene Regulatory Networks
Transcriptome
Theoretical Models
Up-Regulation
Down-Regulation

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2. / Somarelli, Jason A.; Shetler, Samantha; Jolly, Mohit K.; Wang, Xueyang; Bartholf Dewitt, Suzanne; Hish, Alexander J.; Gilja, Shivee; Eward, William C.; Ware, Kathryn E.; Levine, Herbert; Armstrong, Andrew J.; Garcia-Blanco, Mariano.

In: Molecular and Cellular Biology, Vol. 36, No. 19, 2016, p. 2503-2513.

Research output: Contribution to journalArticle

Somarelli, JA, Shetler, S, Jolly, MK, Wang, X, Bartholf Dewitt, S, Hish, AJ, Gilja, S, Eward, WC, Ware, KE, Levine, H, Armstrong, AJ & Garcia-Blanco, M 2016, 'Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2', Molecular and Cellular Biology, vol. 36, no. 19, pp. 2503-2513. https://doi.org/10.1128/MCB.00373-16
Somarelli, Jason A. ; Shetler, Samantha ; Jolly, Mohit K. ; Wang, Xueyang ; Bartholf Dewitt, Suzanne ; Hish, Alexander J. ; Gilja, Shivee ; Eward, William C. ; Ware, Kathryn E. ; Levine, Herbert ; Armstrong, Andrew J. ; Garcia-Blanco, Mariano. / Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2. In: Molecular and Cellular Biology. 2016 ; Vol. 36, No. 19. pp. 2503-2513.
@article{849ef378bde64e7f9f9d7e5c8d4053d1,
title = "Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2",
abstract = "Phenotypic plasticity involves a process in which cells transiently acquire phenotypic traits of another lineage. Two commonly studied types of phenotypic plasticity are epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET). In carcinomas, EMT drives invasion and metastatic dissemination, while MET is proposed to play a role in metastatic colonization. Phenotypic plasticity in sarcomas is not well studied; however, there is evidence that a subset of sarcomas undergo an MET-like phenomenon. While the exact mechanisms by which these transitions occur remain largely unknown, it is likely that some of the same master regulators that drive EMT and MET in carcinomas also act in sarcomas. In this study, we combined mathematical models with bench experiments to identify a core regulatory circuit that controls MET in sarcomas. This circuit comprises the microRNA 200 (miR-200) family, ZEB1, and GRHL2. Interestingly, combined expression of miR-200s and GRHL2 further upregulates epithelial genes to induce MET. This effect is phenocopied by downregulation of either ZEB1 or the ZEB1 cofactor, BRG1. In addition, an MET gene expression signature is prognostic for improved overall survival in sarcoma patients. Together, our results suggest that a miR-200, ZEB1, GRHL2 gene regulatory network may drive sarcoma cells to a more epithelial- like state and that this likely has prognostic relevance.",
author = "Somarelli, {Jason A.} and Samantha Shetler and Jolly, {Mohit K.} and Xueyang Wang and {Bartholf Dewitt}, Suzanne and Hish, {Alexander J.} and Shivee Gilja and Eward, {William C.} and Ware, {Kathryn E.} and Herbert Levine and Armstrong, {Andrew J.} and Mariano Garcia-Blanco",
year = "2016",
doi = "10.1128/MCB.00373-16",
language = "English (US)",
volume = "36",
pages = "2503--2513",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "19",

}

TY - JOUR

T1 - Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of microRNA 200s and GRHL2

AU - Somarelli, Jason A.

AU - Shetler, Samantha

AU - Jolly, Mohit K.

AU - Wang, Xueyang

AU - Bartholf Dewitt, Suzanne

AU - Hish, Alexander J.

AU - Gilja, Shivee

AU - Eward, William C.

AU - Ware, Kathryn E.

AU - Levine, Herbert

AU - Armstrong, Andrew J.

AU - Garcia-Blanco, Mariano

PY - 2016

Y1 - 2016

N2 - Phenotypic plasticity involves a process in which cells transiently acquire phenotypic traits of another lineage. Two commonly studied types of phenotypic plasticity are epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET). In carcinomas, EMT drives invasion and metastatic dissemination, while MET is proposed to play a role in metastatic colonization. Phenotypic plasticity in sarcomas is not well studied; however, there is evidence that a subset of sarcomas undergo an MET-like phenomenon. While the exact mechanisms by which these transitions occur remain largely unknown, it is likely that some of the same master regulators that drive EMT and MET in carcinomas also act in sarcomas. In this study, we combined mathematical models with bench experiments to identify a core regulatory circuit that controls MET in sarcomas. This circuit comprises the microRNA 200 (miR-200) family, ZEB1, and GRHL2. Interestingly, combined expression of miR-200s and GRHL2 further upregulates epithelial genes to induce MET. This effect is phenocopied by downregulation of either ZEB1 or the ZEB1 cofactor, BRG1. In addition, an MET gene expression signature is prognostic for improved overall survival in sarcoma patients. Together, our results suggest that a miR-200, ZEB1, GRHL2 gene regulatory network may drive sarcoma cells to a more epithelial- like state and that this likely has prognostic relevance.

AB - Phenotypic plasticity involves a process in which cells transiently acquire phenotypic traits of another lineage. Two commonly studied types of phenotypic plasticity are epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET). In carcinomas, EMT drives invasion and metastatic dissemination, while MET is proposed to play a role in metastatic colonization. Phenotypic plasticity in sarcomas is not well studied; however, there is evidence that a subset of sarcomas undergo an MET-like phenomenon. While the exact mechanisms by which these transitions occur remain largely unknown, it is likely that some of the same master regulators that drive EMT and MET in carcinomas also act in sarcomas. In this study, we combined mathematical models with bench experiments to identify a core regulatory circuit that controls MET in sarcomas. This circuit comprises the microRNA 200 (miR-200) family, ZEB1, and GRHL2. Interestingly, combined expression of miR-200s and GRHL2 further upregulates epithelial genes to induce MET. This effect is phenocopied by downregulation of either ZEB1 or the ZEB1 cofactor, BRG1. In addition, an MET gene expression signature is prognostic for improved overall survival in sarcoma patients. Together, our results suggest that a miR-200, ZEB1, GRHL2 gene regulatory network may drive sarcoma cells to a more epithelial- like state and that this likely has prognostic relevance.

UR - http://www.scopus.com/inward/record.url?scp=84990036789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990036789&partnerID=8YFLogxK

U2 - 10.1128/MCB.00373-16

DO - 10.1128/MCB.00373-16

M3 - Article

VL - 36

SP - 2503

EP - 2513

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 19

ER -